Advanced Health Past Earnings Performance

Past criteria checks 0/6

Advanced Health has been growing earnings at an average annual rate of 0.5%, while the Healthcare industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 10% per year.

Key information

0.5%

Earnings growth rate

7.7%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate10.0%
Return on equity5.1%
Net Margin-3.1%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

Investors Will Want Advanced Health's (JSE:AVL) Growth In ROCE To Persist

Jun 10
Investors Will Want Advanced Health's (JSE:AVL) Growth In ROCE To Persist

Is Advanced Health (JSE:AVL) A Risky Investment?

Apr 18
Is Advanced Health (JSE:AVL) A Risky Investment?

Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Jan 31
Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Auditors Have Doubts About Advanced Health (JSE:AVL)

Oct 14
Auditors Have Doubts About Advanced Health (JSE:AVL)

Returns At Advanced Health (JSE:AVL) Are On The Way Up

Jun 29
Returns At Advanced Health (JSE:AVL) Are On The Way Up

The Return Trends At Advanced Health (JSE:AVL) Look Promising

Mar 16
The Return Trends At Advanced Health (JSE:AVL) Look Promising

Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Sep 02
Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Does Advanced Health (JSE:AVL) Have A Healthy Balance Sheet?

Jun 26
Does Advanced Health (JSE:AVL) Have A Healthy Balance Sheet?

Here's What To Make Of Advanced Health's (JSE:AVL) Decelerating Rates Of Return

Apr 28
Here's What To Make Of Advanced Health's (JSE:AVL) Decelerating Rates Of Return

Read This Before Selling Advanced Health Limited (JSE:AVL) Shares

Feb 28
Read This Before Selling Advanced Health Limited (JSE:AVL) Shares

Revenue & Expenses Breakdown

How Advanced Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

JSE:AVL Revenue, expenses and earnings (ZAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 22687-2170
30 Sep 22676-2170
30 Jun 22665-2070
31 Mar 22446-4480
31 Dec 21445-4590
30 Sep 21563-3780
30 Jun 21681-2880
31 Mar 21618-8060
31 Dec 20554-13340
30 Sep 20515-14040
30 Jun 20476-14740
31 Dec 19499-3200
30 Sep 19491-3100
30 Jun 19482-3100
31 Dec 18451-2920
30 Sep 18429-3120
30 Jun 18407-3420
31 Mar 18384-4420
31 Dec 17359-4820
30 Sep 17334-4820
30 Jun 17309-4820
31 Mar 17298-4520
31 Dec 16287-4320
30 Sep 16264-3020
30 Jun 16241-1820
31 Mar 16216-3310
31 Dec 1519113610
30 Sep 1518615610
30 Jun 1518017610
31 Mar 1517713530
31 Dec 141749450
30 Sep 141658450
30 Jun 141568450
30 Jun 131269450

Quality Earnings: AVL is currently unprofitable.

Growing Profit Margin: AVL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AVL is unprofitable, but has reduced losses over the past 5 years at a rate of 0.5% per year.

Accelerating Growth: Unable to compare AVL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AVL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.7%).


Return on Equity

High ROE: AVL has a negative Return on Equity (5.11%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies